ONDCP

Balancing medical use with the growing danger of Prescription Drug Diversions.

Balance, yes, balance. Even Gil Kerlikowske, the Director of National Drug Control Policy in the Executive Office of the President,  used the term “balance” in his testimony to a hearing of the House Committee on Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade this morning.   That committee heard submissions from a number of people … Continue reading →